Literature DB >> 34048010

A Mouse Model of Necrotizing Enterocolitis.

Belgacem Mihi1, Wyatt E Lanik1, Qingqing Gong1, Misty Good2.   

Abstract

Necrotizing enterocolitis (NEC) is an acute inflammatory disease that unforeseeably develops in very low birth weight premature infants. NEC is characterized by impairment of the intestinal barrier resulting in intestinal necrosis and multisystem organ failure. Animal models of NEC have contributed significantly to a better understanding of the underlying molecular mechanisms of the disease and facilitated the exploration of potential new therapeutic strategies. Here, we provide a detailed protocol that recapitulates some of the main histological and transcriptional features of human NEC in newborn mice.

Entities:  

Keywords:  Enteric bacteria; Intestinal inflammation; Mucosal barrier; Necrotizing enterocolitis; Neonatal mice

Mesh:

Year:  2021        PMID: 34048010      PMCID: PMC8272439          DOI: 10.1007/978-1-0716-1488-4_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model.

Authors:  Krishnan MohanKumar; Niroop Kaza; Ramasamy Jagadeeswaran; Steven A Garzon; Anchal Bansal; Ashish R Kurundkar; Kopperuncholan Namachivayam; Juan I Remon; C Rekha Bandepalli; Xu Feng; Joern-Hendrik Weitkamp; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

2.  Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.

Authors:  Ibrahim Yazji; Chhinder P Sodhi; Elizabeth K Lee; Misty Good; Charlotte E Egan; Amin Afrazi; Matthew D Neal; Hongpeng Jia; Joyce Lin; Congrong Ma; Maria F Branca; Thomas Prindle; Ward M Richardson; John Ozolek; Timothy R Billiar; David G Binion; Mark T Gladwin; David J Hackam
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

Review 3.  Development of the gut microbiota in infancy and its impact on health in later life.

Authors:  Masaru Tanaka; Jiro Nakayama
Journal:  Allergol Int       Date:  2017-08-18       Impact factor: 5.836

Review 4.  Necrotizing enterocolitis.

Authors:  Josef Neu; W Allan Walker
Journal:  N Engl J Med       Date:  2011-01-20       Impact factor: 91.245

Review 5.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

6.  Pathology of neonatal necrotizing enterocolitis: a ten-year experience.

Authors:  W A Ballance; B B Dahms; N Shenker; R M Kliegman
Journal:  J Pediatr       Date:  1990-07       Impact factor: 4.406

Review 7.  Necrotizing enterocolitis and preterm infant gut bacteria.

Authors:  Barbara B Warner; Phillip I Tarr
Journal:  Semin Fetal Neonatal Med       Date:  2016-06-22       Impact factor: 3.926

8.  Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9.

Authors:  Misty Good; Chhinder P Sodhi; John A Ozolek; Rachael H Buck; Karen C Goehring; Debra L Thomas; Amit Vikram; Kyle Bibby; Michael J Morowitz; Brian Firek; Peng Lu; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

Review 9.  Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.

Authors:  Misty Good; Chhinder P Sodhi; David J Hackam
Journal:  Expert Rev Clin Immunol       Date:  2014-06-05       Impact factor: 4.473

10.  Trinitrobenzene sulfonic acid-induced intestinal injury in neonatal mice activates transcriptional networks similar to those seen in human necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Feng Cheng; Rays H Y Jiang; Jaime Flores-Torres; Benjamin A Torres; Akhil Maheshwari
Journal:  Pediatr Res       Date:  2016-09-22       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.